SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-16-785269
Filing Date
2016-12-05
Accepted
2016-12-05 17:10:33
Documents
16
Period of Report
2016-12-05

Document Format Files

Seq Description Document Type Size
1 6-K d289093d6k.htm 6-K 13923
2 EX-99.1 d289093dex991.htm EX-99.1 333884
3 GRAPHIC g289093g1205235019904.jpg GRAPHIC 4205
4 GRAPHIC g289093g1205235020107.jpg GRAPHIC 16480
5 GRAPHIC g289093g1205235020451.jpg GRAPHIC 14066
6 GRAPHIC g289093g1205235020654.jpg GRAPHIC 17293
7 GRAPHIC g289093g1205235020951.jpg GRAPHIC 22158
8 GRAPHIC g289093g1205235021247.jpg GRAPHIC 20929
9 GRAPHIC g289093g1205235021544.jpg GRAPHIC 6705
10 GRAPHIC g289093g1205235021872.jpg GRAPHIC 11367
11 GRAPHIC g289093g1205235022169.jpg GRAPHIC 12533
12 GRAPHIC g289093g1205235022372.jpg GRAPHIC 13393
13 GRAPHIC g289093g1205235022669.jpg GRAPHIC 19003
14 GRAPHIC g289093g1205235022935.jpg GRAPHIC 29799
15 GRAPHIC g289093g1205235023247.jpg GRAPHIC 18045
16 GRAPHIC g289093g1205235023497.jpg GRAPHIC 9190
  Complete submission text file 0001193125-16-785269.txt   647395
Mailing Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3
Business Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3 (450) 687-2262
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0228
Type: 6-K | Act: 34 | File No.: 001-35776 | Film No.: 162034457
SIC: 2834 Pharmaceutical Preparations